for trials without intervention aortic stenosis
Conditions
Interventions
The patients with severe aortic stenosis who undergo transcatheter aortic valve replacement procedure.
Treatment
The patients with severe aortic stenosis
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patients with severe aortic stenosis who undergo transcatheter aortic valve replacement procedure.
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30 days mortality 30 days after TAVR procedure date Rates of mortality at 30 days follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| In-hospital major adverse cardiovascular events (stroke , MI , Vascular complication) from enroll date to discharge date Rates of In-hospital MACE,In-hospital mortality from enroll date to discharge date Rates of In-hospital mortality,30 days major adverse cardiovascular events 30days after TAVR procedure date Rates of MACE at 30 days follow-up,1 Year mortality 1 year after TAVR procedure date Rates of mortality at 1 year follow-up,1 Year major adverse cardiovascular events 1 year after TAVR procedure date Rates of MACE at 1 year follow-up,Factors of baseline demographic and parameters of predictors for MACE and mortality from baseline visit to 1 year follow-up visit Multiple logistic regression was used to test the relationship of clinical predictors and outcomes | — |
Countries
Thailand
Contacts
Public ContactNattawut Wongpraparut
Division of Cardiology, Faculty of Medicine Siriraj Hospital
Outcome results
None listed